Yoon Kun-Ho, Lee Jin-Hee, Kim Ji-Won, Cho Jae Hyoung, Choi Yoon-Hee, Ko Seung-Hyun, Zimmet Paul, Son Ho-Young
Divison of Endocrinology and Metabolism, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Lancet. 2006 Nov 11;368(9548):1681-8. doi: 10.1016/S0140-6736(06)69703-1.
The proportions of people with type 2 diabetes and obesity have increased throughout Asia, and the rate of increase shows no sign of slowing. People in Asia tend to develop diabetes with a lesser degree of obesity at younger ages, suffer longer with complications of diabetes, and die sooner than people in other regions. Childhood obesity has increased substantially and the prevalence of type 2 diabetes has now reached epidemic levels in Asia. The health consequences of this epidemic threaten to overwhelm health-care systems in the region. Urgent action is needed, and advocacy for lifestyle changes is the first step. Countries should review and implement interventions, and take a comprehensive and integrated public-health approach. At the level of primary prevention, such programmes can be linked to other non-communicable disease prevention programmes that target lifestyle-related issues. The cost of inaction is clear and unacceptable.
2型糖尿病和肥胖症患者的比例在亚洲各地都有所上升，且上升速度没有减缓的迹象。与其他地区的人相比，亚洲人往往在更年轻的时候、肥胖程度较低的情况下就患上糖尿病，糖尿病并发症的患病时间更长，死亡时间更早。儿童肥胖现象大幅增加，2型糖尿病的患病率在亚洲现已达到流行程度。这一流行病对健康造成的影响可能会压垮该地区的医疗保健系统。需要立即采取行动，倡导生活方式改变是第一步。各国应审查并实施干预措施，采取全面综合的公共卫生方法。在一级预防层面，此类方案可与针对生活方式相关问题的其他非传染性疾病预防方案相挂钩。不作为的代价显而易见且令人无法接受。
